The redesigned accountable care organization (ACO) model is called the Realizing Equity, Access, and Community Health model and is scheduled to begin in 2023.
CMS said Thursday it is redesigning its accountable care organization (ACO) model away from its Global and Professional Direct Contracting (GPDC) model into one that focuses on health equity.
Slated to begin in 2023, the ACO Realizing Equity, Access, and Community Health (REACH) Model “addresses stakeholder feedback, participant experience, and Administration priorities, including CMS’ commitment to advancing health equity,” CMS said in a statement.
In addition, CMS is canceling the Geographic Direct Contracting Model, which was announced in December 2020 by the Trump administration but was paused in March 2021.
“The Biden-Harris Administration remains committed to promoting value-based care that improves the health care experience of people with Medicare, Medicaid and Marketplace coverage,” CMS Administrator Chiquita Brooks-LaSure said in a statement. “To fulfill that commitment, CMS, through the Innovation Center, is testing new models of health care service delivery and payment to improve the quality of care that people receive, including those in underserved communities. The Innovation Center is making improvements to existing models and launching new models to increase participation in our portfolio, and CMS will be a strong collaborator to health care providers that participate in those models.”
GPDC will continue until December 31, 2022, and then will transition to the REACH model, but for the rest of the year, CMS said it will operate GPDC "with more robust and real-time monitoring of quality and costs."
The first performance year of REACH will start on January 1, 2023, and the model performance period will run through 2026.
Earlier this month, the National Association of ACOs (NAACOS) sent a letter to HHS asking that GPDC be overhauled instead of canceled. The letter, signed by more than 200 organizations, said that ending GPDC would stall the movement to value-based care.
In a statement released Thursday, NAACOS praised CMS and said REACH was basically a continuation of GPDC, "albeit with numerous changes and a new name."
"Many of the criticisms against Direct Contracting were a product of great misunderstanding about the model and the overall shift to value-based payment," NAACOS said. "Instead, keeping the model with additional focus on equity, increased provider governance, improvements to risk adjustment, and other changes is best moving forward." CMS adopted many of the changes the organization has been lobbying for, NAACOS said.
Prenatal PFAS Exposure Alters Infant Vaccine-Related Immune Cells
August 1st 2025Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), a class of persistent environmental pollutants, was linked to significant shifts in infant T helper cell development, raising concerns about long-term effects on vaccine response, immune regulation, and disease susceptibility.
Read More
Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease
July 31st 2025During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.
Read More
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More